Therapeutics for lymphatic disease: The role of the pharmaceutical and biotechnology sector

Lymphatic Research and Biology

Volumn 3, Issue 3, 2005, Pages 103-104

  Rockson, Stanley G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GROWTH HORMONE; NEUTRALIZING ANTIBODY; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 3;

ANGIOOSTEOHYPERTROPHY SYNDROME; BIOTECHNOLOGY; BREAST CANCER; DRUG INDUSTRY; EDITORIAL; GENE THERAPY; HUMAN; LYMPHANGIOGENESIS; LYMPHANGIOMATOSIS; LYMPHATIC SYSTEM; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; MASTECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BIOTECHNOLOGY; DRUG INDUSTRY; HUMANS; LYMPHATIC DISEASES; PHARMACEUTICAL PREPARATIONS;

EID: 27744576428     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2005.3.103     Document Type: Editorial

References (9)

1. Rockson SG. Lymphedema. Am J Med 2001;110:288-295.
2. Paskett E. Arm Swelling Common Among Young Breast Cancer Patients. In:
3. McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: A review. Cancer 2005; 104:457-466.
4. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001;98:12677-12682.
5. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003;111:717-725.
6. Ochoa ER, Vacanti JP. An overview of the pathology and approaches to tissue engineering. Ann N Y Acad Sci 2002;979:10-26; discussion 35-38.
7. Niklason LE, Koh J, Solan A. Tissue engineering of the lymphatic system. Ann NY Acad Sci 2002;979:27-34; discussion 35-38.
8. Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 2005;97:14-21.
9. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Yla-Herttuala S, Jackson DG, Alitalo K, McDonald DM. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005;115:247-257.